Traditional Chinese medicine composition for treating polycystic kidney disease, and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine composition for treating a polycystic kidney disease, which is mainly prepared by the following raw material medicine in parts by weight: 15-30 parts of pilose asiabell root, 15-30 parts of astragalus root, 10-15 parts of Chinese angelica root, 10-15 parts of red peony root, 10-15 parts of white peony root, 10-15 parts of burreed rhizome, 10-30 parts of ternate buttercup root, 1-2 parts of pangolin scales powder, 10-15 parts of plantain seed, 10-15 parts of white mustard seed, 10-15 parts of semenvaccariae, 10-15 parts of rhizome of drynaria, 10-15 parts of duchesnea indica and 10-15 parts of hedyotidis herba. Besides, the invention also discloses a method for preparing the traditional Chinese medicine composition. The traditional Chinese medicine composition has the function of improving the kidney function, renal tubules and glomeruli of a polycystic kidney disease patient, can effectively improve the clinical symptoms of patients such as waist and knee weakness, lower back swelling pain or sharp pain, physical and mental fatigue, intolerance to cold and cold limbs and limb numbness, can better treat the polycystic kidney disease, is convenient to take, and small in dosage, has no toxic side effect and is praised by patients.

Description

Technical field: [0001] The invention belongs to the field of traditional Chinese medicine and relates to a compound Chinese medicine preparation, in particular to a traditional Chinese medicine composition for treating polycystic kidney disease and a preparation method thereof. Background technique: [0002] Polycystic kidney disease (PKD) is one of the most common hereditary kidney diseases in humans. Its incidence in the world is about 1 / 1000-1 / 400. The main pathological feature is the extensive formation of cysts in both kidneys. Sexual growth, eventually destroying the structure and function of the kidney, and can involve the liver, cardiovascular and many other organs. The age of onset is generally 30-40 years old, and more than 50% of patients aged 60 years enter end-stage renal failure, accounting for about 10% of the causes of end-stage renal failure. About 2.7% of hemodialysis patients are caused by ADPKD (autosomal dominant polycystic kidney disease), and about 3...

AI Technical Summary

Problems solved by technology

However, there is no unified TCM syndrome differentiation method and standard for this disease at present, and clinicians mostly use their own experience to differentiate syndromes and types

In terms of traditional Chinese medicines for effective treatment, although the curative effects of several single medicines have been verified by experiments, there are still few reports on the specific curative effects of Chinese herbal medicines.

Images